Mark Campbell - Vice President, Programme Management
Mark Campbell joined the Synexus programme management team in 2014. Prior to joining Synexus, Mark held various senior permanent and consulting positions with companies such as, Amgen, Fresenius Biotech, Noxxon Pharma, Alere and Johnson and Johnson.
As the Vice President of the Programme Management team, Mark’s responsibilities include managing every stage of the trials process as well as focusing on patient centricity strategy. This strategy further promotes customer understanding of effective patient centricity goals, from which customers can obtain patient and investigator insights.